ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 21 of 1150 for:    cataract

Congenital Cataract With Persistent Fetal Vasculature

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03341624
Recruitment Status : Recruiting
First Posted : November 14, 2017
Last Update Posted : November 14, 2017
Sponsor:
Information provided by (Responsible Party):
Yune Zhao, Wenzhou Medical University

Brief Summary:
To observe the clinical characteristics and surgical treatment of 24 cases of congenital cataract complicated with Persistent Fetal Vasculature (PFV) in 28 cases of congenital cataract in our hospital.

Condition or disease Intervention/treatment Phase
Persistent Fetal Vasculature Congenital Cataract Procedure: cataract surgery cataract extraction and intraocular implantation Not Applicable

Detailed Description:
methods the clinical data of 28 eyes of 24 children with congenital cataract complicated with PFV who underwent surgical treatment in our hospital were analyzed retrospectively.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Official Title: Surgical Treatment and Prognosis of Congenital Cataract With Persistent Fetal Vasculature
Actual Study Start Date : January 1, 2017
Estimated Primary Completion Date : December 31, 2018
Estimated Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cataract

Arm Intervention/treatment
Experimental: cataract surgery cataract extraction and intraocular implanta Procedure: cataract surgery cataract extraction and intraocular implantation



Primary Outcome Measures :
  1. visual acuity [ Time Frame: 2 years ]
    level1:visual acuity≥0.3;level 2:0.1≤visual acuity<0.3;level 3:0.02 ≤visual acuity<0.1;level 4:≤0.02



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • congenital cataract with Persistent Fetal Vasculature

Exclusion Criteria:

  • congenital cataract with no Persistent Fetal Vasculature

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03341624


Contacts
Contact: Man Hu, MD +86-0571-88185666 64344308@qq.com

Locations
China, Zhejiang
Eye Hospital of Wenzhou Medical College Recruiting
Wenzhou, Zhejiang, China, 325027
Contact: Man Hu, MD    13738069080    64344308@qq.com   
Sponsors and Collaborators
Yune Zhao

Responsible Party: Yune Zhao, Director, Wenzhou Medical University
ClinicalTrials.gov Identifier: NCT03341624     History of Changes
Other Study ID Numbers: HM-PFV-001
First Posted: November 14, 2017    Key Record Dates
Last Update Posted: November 14, 2017
Last Verified: November 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Yune Zhao, Wenzhou Medical University:
persistent fetal vasculature
congenital cataract

Additional relevant MeSH terms:
Cataract
Persistent Hyperplastic Primary Vitreous
Retinal Diseases
Lens Diseases
Eye Diseases
Eye Abnormalities
Congenital Abnormalities